JP2015501791A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015501791A5 JP2015501791A5 JP2014540950A JP2014540950A JP2015501791A5 JP 2015501791 A5 JP2015501791 A5 JP 2015501791A5 JP 2014540950 A JP2014540950 A JP 2014540950A JP 2014540950 A JP2014540950 A JP 2014540950A JP 2015501791 A5 JP2015501791 A5 JP 2015501791A5
- Authority
- JP
- Japan
- Prior art keywords
- methoxyethyl
- gataparsen
- m5ru
- manufactured
- thoxyethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2011-0117082 | 2011-11-10 | ||
| KR1020110117082A KR101383324B1 (ko) | 2011-11-10 | 2011-11-10 | 신규한 유전자 전달용 조성물 |
| PCT/KR2012/009443 WO2013070010A1 (en) | 2011-11-10 | 2012-11-09 | Novel composition for gene delivery |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015501791A JP2015501791A (ja) | 2015-01-19 |
| JP2015501791A5 true JP2015501791A5 (enExample) | 2015-05-21 |
| JP5923177B2 JP5923177B2 (ja) | 2016-05-24 |
Family
ID=48290305
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014540950A Active JP5923177B2 (ja) | 2011-11-10 | 2012-11-09 | 新規な遺伝子伝達用組成物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US9173853B2 (enExample) |
| EP (1) | EP2776056B1 (enExample) |
| JP (1) | JP5923177B2 (enExample) |
| KR (1) | KR101383324B1 (enExample) |
| ES (1) | ES2621403T3 (enExample) |
| WO (1) | WO2013070010A1 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101494594B1 (ko) | 2011-08-30 | 2015-02-23 | 주식회사 종근당 | 약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물 |
| KR101586791B1 (ko) | 2012-12-28 | 2016-01-19 | 주식회사 종근당 | ＧｎＲＨ 유도체의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물 |
| AU2014213125B2 (en) | 2013-01-31 | 2016-06-02 | Chong Kun Dang Pharmaceutical Corp. | Biaryl- or heterocyclic biaryl-substituted cyclohexene derivative compounds as CETP inhibitors |
| KR101601035B1 (ko) | 2013-02-28 | 2016-03-08 | 주식회사 종근당 | 키토산 및 액상결정 형성 물질을 포함하는 유전자 전달용 조성물 |
| CL2014003514A1 (es) * | 2014-12-23 | 2015-05-08 | Univ De Concepción | Nanopartículas a base de quitosano para el transporte de péptidos con actividad en el sistema nervioso central. |
| KR101916193B1 (ko) * | 2016-08-25 | 2018-11-07 | 주식회사 파마리서치프로덕트 | 핵산 및 키토산을 포함하는 관절강 주사용 조성물 |
| ES2994451T3 (en) | 2017-04-20 | 2025-01-24 | Atyr Pharma Inc | Compositions for treating lung inflammation |
| WO2019195770A1 (en) | 2018-04-06 | 2019-10-10 | Atyr Pharma, Inc. | Compositions and methods comprising anti-nrp2 antibodies |
| IL317993B2 (en) | 2018-07-03 | 2025-11-01 | Gilead Sciences Inc | Antibodies directed against HIV gp120 and methods of use |
| AU2019312366B2 (en) | 2018-07-26 | 2025-08-14 | Atyr Pharma, Inc. | Compositions and methods for treating NRP2-associated diseases |
| CN114245807B (zh) | 2019-06-25 | 2025-05-02 | 吉利德科学公司 | Flt3l-fc融合蛋白和使用方法 |
| AU2020315598B2 (en) | 2019-07-16 | 2024-12-12 | Gilead Sciences, Inc. | HIV vaccines and methods of making and using |
| HRP20241379T1 (hr) | 2019-09-30 | 2024-12-20 | Gilead Sciences, Inc. | Cjepiva za hbv i postupci za liječenje hbv |
| AU2020358854B2 (en) | 2019-10-03 | 2026-08-13 | Atyr Pharma, Inc. | Compositions and methods comprising anti-NRP2 antibodies |
| CA3128035A1 (en) | 2020-08-13 | 2022-02-13 | Bioasis Technologies, Inc. | Combination therapies for delivery across the blood brain barrier |
| TWI815194B (zh) | 2020-10-22 | 2023-09-11 | 美商基利科學股份有限公司 | 介白素2-Fc融合蛋白及使用方法 |
| CA3259040A1 (en) | 2022-07-12 | 2024-01-18 | Gilead Sciences, Inc. | HIV Immunogenic Polypeptides and Vaccines and Their Uses |
| US20260209367A1 (en) | 2024-11-22 | 2026-07-23 | Gilead Sciences, Inc. | SINGLE IMMUNOGLOBULIN DOMAIN BISPECIFIC ANTIBODIES AGAINST IL 10R alpha AND beta SUBUNITS AND METHODS OF USE |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6008202A (en) | 1995-01-23 | 1999-12-28 | University Of Pittsburgh | Stable lipid-comprising drug delivery complexes and methods for their production |
| US7052678B2 (en) | 1997-09-15 | 2006-05-30 | Massachusetts Institute Of Technology | Particles for inhalation having sustained release properties |
| JP2002509116A (ja) * | 1998-01-16 | 2002-03-26 | ザ・ジョーンズ・ホプキンス・ユニバーシティ | 核酸およびサイトカインの単一溶媒での同時輸送による遺伝子免疫 |
| US20030134810A1 (en) * | 2001-10-09 | 2003-07-17 | Chris Springate | Methods and compositions comprising biocompatible materials useful for the administration of therapeutic agents |
| CA2516188C (en) * | 2003-02-14 | 2012-04-17 | University Of South Florida | Chitosan-derivatives for gene delivery and expression |
| KR100882611B1 (ko) * | 2006-11-14 | 2009-02-12 | 주식회사 키토라이프 | 표적 리간드로서 폴릭산이 도입된 유전자 전달체용저분자량 수용성 키토산 나노입자 및 이의 제조방법 |
| KR100825519B1 (ko) * | 2007-01-05 | 2008-04-25 | 주식회사 바이오폴리메드 | 키토산 기재 고분자 접합체 및 그 제조방법 |
| US20110038941A1 (en) | 2007-12-27 | 2011-02-17 | The Ohio State University Research Foundation | Lipid Nanoparticle Compositions and Methods of Making and Using the Same |
| KR101494594B1 (ko) | 2011-08-30 | 2015-02-23 | 주식회사 종근당 | 약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물 |
-
2011
- 2011-11-10 KR KR1020110117082A patent/KR101383324B1/ko active Active
-
2012
- 2012-11-09 WO PCT/KR2012/009443 patent/WO2013070010A1/en not_active Ceased
- 2012-11-09 EP EP12847217.2A patent/EP2776056B1/en active Active
- 2012-11-09 JP JP2014540950A patent/JP5923177B2/ja active Active
- 2012-11-09 ES ES12847217.2T patent/ES2621403T3/es active Active
- 2012-11-09 US US14/357,375 patent/US9173853B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Xiong et al. | Amphiphilic block co-polymers: preparation and application in nanodrug and gene delivery | |
| JP2013542247A5 (enExample) | ||
| EA201170039A1 (ru) | Полимерные частицы, нагруженные лекарственным средством, и способы их получения и применения | |
| JP2013507423A5 (enExample) | ||
| EA201290482A1 (ru) | Стабильные составы для лиофилизации терапевтических частиц | |
| WO2014004436A3 (en) | Crystalline anti-human il-23 antibodies | |
| RU2013141449A (ru) | Модуляция роста бифидобактерий в сочетании с олигосахаридами, находящимися в материнском молоке | |
| EA201890236A1 (ru) | Полициклические карбамоилпиридоновые соединения и их фармацевтическое применение | |
| PH12014502524B1 (en) | Carboxylic acid compounds | |
| SG10201804024VA (en) | Formulations of azaindole compounds | |
| EA201400311A1 (ru) | Аминозамещенные имидазопиридазины | |
| WO2014066468A8 (en) | Stable, low viscosity antibody formulation | |
| JP2011105738A5 (enExample) | ||
| JP2015007131A5 (enExample) | ||
| MY180145A (en) | Cenicriviroc compositions and methods of making and using the same | |
| JP2013525333A5 (enExample) | ||
| MA35130B1 (fr) | Composition comprenant de l'aflibercept, de l'acide folinique, du 5-fluoro-uracile (5-fu) et de l'irinocetan (folfiri) | |
| JP2017517533A5 (enExample) | ||
| JP2014097964A5 (enExample) | ||
| PH12015500702B1 (en) | Dialysis a agent comprising acetic acid and acetate, and two-part dialysis agent using same | |
| JP2015509075A5 (enExample) | ||
| JP2013518036A5 (enExample) | ||
| HRP20151009T1 (hr) | Dvoslojna tableta koja sadrži elvitegravir, kobicistat, emtricitabin i tenofovir | |
| BR112012008666A2 (pt) | processo para a preparação de um pó, formulação, e, uso do pó preparado por um processo | |
| WO2014081968A8 (en) | Compositions of low sodium salt and methods of making and using |